]>
IRCT20150511022218N5 IRCT 2019-04-06 Neyshabour University of Medical Sciences The effect of Alhagi distillate on ureteral stone expulsion The effect of Alhagi distillate on ureteral stone expulsion 2019-07-23 anticipated 110 Complete https://irct.ir/trial/38066 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In the present study, the subjects were divided into intervention and control groups in blocks of 4 using randomized block method. For this purpose, first, all possible states were assigned, as half of the subjects to group A (intervention group) and the other half to group B (control group), including AABB, BBAA, ABAB, BABA, ABBA, BAAB. Then, one of the digits 1 to 6 was assigned to each of the combinations of 4, and choices from 1 to 6 were randomly selected with replacement. The selected blocks were recorded as a serial sequence. Each individual entering the study received a treatment A or B in terms of sequence. Random selection of the blocks continued until reaching the sample size of the study. 3 ureteral stone. Intervention 1: Intervention group: In this study The intervention group, in addition to receiving routine treatments (daily one 0.4 mg tamsulosin capsule(Farabi Pharmacy), diclofenac suppositories of 100 mg(Sobhan Pharmacy) and Cefixime 200 mg(Farabi Pharmacy) every twelve hours), will receive 150 cc of Alhagi distillate(Qadah Kashan Co) daily in 3 divided doses for a period of 4 weeks. Intervention 2: Control group:In this study, patients in the control group daily received one 0.4 mg tamsulosin capsule(Farabi Pharmacy), diclofenac suppositories of 100 mg(Sobhan Pharmacy) and Cefixime 200 mg(Farabi Pharmacy) every twelve hours (routine intervention determined by a physician based on American nephrology protocols). No - There is not a plan to make this available Justification or reason for not sharing IPD is The researcher only intends to publish the article and there is no plan for publication in this study
public Vahid Moeini
Neyshabur University of Medical Sciences, Janbazan Blvd, Qods Town, Neyshabur
Neyshabur Iran (Islamic Republic of) 6623451124 +98 51 4334 4711 v.moini@yahoo.com Neyshabour University of Medical Sciences scientific Vahid Moeini
Neyshabur University of Medical Sciences, Janbazan Blvd, Qods Town, Neyshabur
Neyshabur Iran (Islamic Republic of) 6623451124 +98 51 4334 4711 v.moini@yahoo.com Neyshabour University of Medical Sciences Iran (Islamic Republic of) Having Consent form All patients with renal colic pain with kidney stones diagnosis Ureteral stones smaller than 1 cm Age between 20 and 60 years 20 years 60 years Both Severe or progressive hydronephrosis Urinary tract infection The patient's symptoms can not be tolerated N21 Calculus of lower urinary tract Treatment - Other Treatment - Drugs Intervention group: In this study The intervention group, in addition to receiving routine treatments (daily one 0.4 mg tamsulosin capsule(Farabi Pharmacy), diclofenac suppositories of 100 mg(Sobhan Pharmacy) and Cefixime 200 mg(Farabi Pharmacy) every twelve hours), will receive 150 cc of Alhagi distillate(Qadah Kashan Co) daily in 3 divided doses for a period of 4 weeks. Control group:In this study, patients in the control group daily received one 0.4 mg tamsulosin capsule(Farabi Pharmacy), diclofenac suppositories of 100 mg(Sobhan Pharmacy) and Cefixime 200 mg(Farabi Pharmacy) every twelve hours (routine intervention determined by a physician based on American nephrology protocols). The amount of stone disposal. Timepoint: Check the presence and exact location of the stone before the intervention and one week after the intervention. Method of measurement: Using a checklist that includes: Clinical examination, patient interview, and ultrasound. Neyshabour University of Medical Sciences Approved 2018-04-15 Ethics Committee of Neyshabur University of Medical Sciences Neyshabur University of Medical Sciences, Janbazan Blvd, Qods Town, Neyshabur Neyshabur Razavi Khorasan Iran (Islamic Republic of)